These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19916573)

  • 1. In silico structural and functional analysis of fragments of the ankyrin repeat protein p18(INK4c).
    Sklenovsý P; Otyepka M
    J Biomol Struct Dyn; 2010 Feb; 27(4):521-40. PubMed ID: 19916573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two C-terminal ankyrin repeats form the minimal stable unit of the ankyrin repeat protein p18INK4c.
    Sklenovský P; Banás P; Otyepka M
    J Mol Model; 2008 Aug; 14(8):747-59. PubMed ID: 18481120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of the conformational stability of cyclin-dependent kinase (CDK) 4-interacting ankyrin repeat (AR) proteins.
    Guo Y; Mahajan A; Yuan C; Joo SH; Weghorst CM; Tsai MD; Li J
    Biochemistry; 2009 May; 48(19):4050-62. PubMed ID: 19320462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments.
    Interlandi G; Wetzel SK; Settanni G; Plückthun A; Caflisch A
    J Mol Biol; 2008 Jan; 375(3):837-54. PubMed ID: 18048057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
    Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics study of the stabilities of consensus designed ankyrin repeat proteins.
    Yu H; Kohl A; Binz HK; Plückthun A; Grütter MG; van Gunsteren WF
    Proteins; 2006 Nov; 65(2):285-95. PubMed ID: 16948156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A minimum folding unit in the ankyrin repeat protein p16(INK4).
    Zhang B; Peng Zy
    J Mol Biol; 2000 Jun; 299(4):1121-32. PubMed ID: 10843863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue-resolved stability of full-consensus ankyrin repeat proteins probed by NMR.
    Wetzel SK; Ewald C; Settanni G; Jurt S; Plückthun A; Zerbe O
    J Mol Biol; 2010 Sep; 402(1):241-58. PubMed ID: 20654623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module.
    Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG
    J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankyrin repeat: a unique motif mediating protein-protein interactions.
    Li J; Mahajan A; Tsai MD
    Biochemistry; 2006 Dec; 45(51):15168-78. PubMed ID: 17176038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding and unfolding mechanism of highly stable full-consensus ankyrin repeat proteins.
    Wetzel SK; Settanni G; Kenig M; Binz HK; Plückthun A
    J Mol Biol; 2008 Feb; 376(1):241-57. PubMed ID: 18164721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and folding of the tumour suppressor protein p16.
    Tang KS; Guralnick BJ; Wang WK; Fersht AR; Itzhaki LS
    J Mol Biol; 1999 Jan; 285(4):1869-86. PubMed ID: 9917418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the CDK4/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16INK4 mutations.
    Venkataramani R; Swaminathan K; Marmorstein R
    Nat Struct Biol; 1998 Jan; 5(1):74-81. PubMed ID: 9437433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfolding transition state and intermediates of the tumor suppressor p16INK4a investigated by molecular dynamics simulations.
    Interlandi G; Settanni G; Caflisch A
    Proteins; 2006 Jul; 64(1):178-92. PubMed ID: 16596641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine beta-hydroxylation stabilizes the ankyrin repeat domain fold.
    Kelly L; McDonough MA; Coleman ML; Ratcliffe PJ; Schofield CJ
    Mol Biosyst; 2009 Jan; 5(1):52-8. PubMed ID: 19081931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the denaturation of human alpha-lactalbumin in urea by molecular dynamics simulations.
    Smith LJ; Jones RM; van Gunsteren WF
    Proteins; 2005 Feb; 58(2):439-49. PubMed ID: 15558602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: deciphering the effect of intermolecular interactions on computational structure prediction of the p27Kip1 protein bound to the cyclin A-cyclin-dependent kinase 2 complex.
    Verkhivker GM
    Proteins; 2005 Feb; 58(3):706-16. PubMed ID: 15609350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
    Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
    Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.